Caveolin-1, E-cadherin and β-catenin in gastric carcinoma, precancerous tissues and chronic non-atrophic gastritis

Chinese Journal of Cancer Research

Volumn 24, Issue 1, 2012, Pages 23-28

  Sun, Guo Yang ^a   Wu, Jun Xia ^b   Wu, Jian Sheng ^a   Pan, Yu Ting ^a   Jin, Rong ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b Shaoxing Municipal People's Hospital   (China)

Author keywords

B catenin; Caveolin 1; E cadherin; Gastric carcinoma; Immunohistochemistry

Indexed keywords

BETA CATENIN; CAVEOLIN 1; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CHRONIC GASTRITIS; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRECANCER; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; TUMOR VOLUME;

EID: 84863695843     PISSN: 10009604     EISSN: 19930631     Source Type: Journal    
DOI: 10.1007/s11670-012-0023-0     Document Type: Article

References (24)

1. Tamura G. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol 2006; 12:192-8. (Pubitemid 43336916)
2. Lauwers GY. Defining the pathologic diagnosis of metaplasia, atrophy, dysplasia, and gastric adenocarcinoma. J Clin Gastroenterol 2003; 36(5 Suppl):S37-43. (Pubitemid 36459118)
3. Williams TM, Lisanti MP. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 2005; 288:C494-506. (Pubitemid 40229478)
4. Lu Z, Ghosh S, Wang Z, et al. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 2003; 4:499-515. (Pubitemid 38050046)
5. Couffinhal T, Dufourcq P, Duplàa C. Beta-catenin nuclear activation: common pathway between Wnt and growth factor signaling in vascular smooth muscle cell proliferation? Circ Res 2006; 99:1287-9. (Pubitemid 44949663)
6. Zhou YN, Xu CP, Han B, et al. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol 2002; 8:987-93. (Pubitemid 35446407)
7. Zhou YN, Li M. Relationship between abnormal expression of beta-catenin in gastric carcinoma and survival. Ai Zheng (in Chinese) 2002; 21:536-40.
8. Huang MF, Zhu YQ, Chen ZF, et al. Syndecan-1 and E-cadherin expression in differentiated type of early gastric cancer. World J Gastroenterol 2005; 11:2975-80.
9. Burgermeister E, Xing X, Röcken C, et al. Differential expression and function of caveolin-1 in human gastric cancer progression. Cancer Res 2007; 67:8519-26. (Pubitemid 47437426)
10. Torres VA, Tapia JC, Rodríguez DA, et al. Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin. 2006; J Cell Sci 119:1812-23. (Pubitemid 43811007)
11. Galbiati F, Volonte D, Brown AM, et al. Caveolin-1 expression inhibits Wnt/beta-catenin/Lef-1 signaling by recruiting beta-catenin to caveolae membrane domains. J Biol Chem 2000; 275:23368-77. (Pubitemid 30646240)
12. Chan AO. E-cadherin in gastric cancer. World J Gastroenterol 2006; 12:199-203. (Pubitemid 43336917)
13. Racine C, Belanger M, Hirabayashi H, et al. Reduction of caveolin 1 gene expression in lung carcinoma cell lines. Biochem Biophys Res Commun 1999; 255:580-6. (Pubitemid 29294841)
14. Joo YE, Park CS, Kim HS, et al. Prognostic significance of E-cadherin/catenin complex expression in gastric cancer. J Korean Med Sci 2000; 15:655-66.
15. Utsunomiya T, Doki Y, Takemoto H, et al. Clinical significance of disordered beta-catenin expression pattern in human gastric cancers. Gastric Cancer 2000; 3:193-201. (Pubitemid 32290726)
16. Chu YQ, Ye ZY, Tao HQ, et al. Relationship between cell adhering molecules expression and the biological behavior of gastric carcinoma. World J Gastroenterol 2008; 14:1990-6.
17. Wang L, Zhang F, Wu PP, et al. Disordered beta-catenin expression and E-cadherin/CDH1 promoter methylation in gastric carcinoma. World J Gastroenterol 2006; 12:4228-31. (Pubitemid 44376909)
18. Sobin LH, Wittekind C. International Union Against Cancer (UICC) TNM classification of malignant tumours. 6th edition. New York: Wiley; 2002.
19. Williams TM, Medina F, Badano I, et al. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. J Biol Chem 2004; 279:51630-46.
20. Nakanishi Y, Ochiai A, Akimoto S, et al. Expression of E-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions. Oncology 1997; 54:158-65. (Pubitemid 27101765)
21. Yoon CS, Hyung WJ, Lee JH, et al. Expression of S100A4, E-cadherin, alpha- and beta-catenin in gastric adenocarcinoma. Hepatogastroenterology 2008; 55:1916-20.
22. Williams TM, Sotgia F, Lee H, et al. Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells. Am J Pathol 2006; 169:1784-801. (Pubitemid 351182008)
23. Luo HM, Tang SS, Liao DF, et al. Effect of caveolin-1 on growth of human gastric cancer cell line MGC803. Shi Jie Hua Ren Xiao Hua Za Zhi (in Chinese) 2006; 14:1448-52.
24. Luo HM, Zhang MS, Tang SS, et al. Study of the relationship between suspected anti-oncogene caveolin-1 expression and gastric carcinoma biological behavior. Zhong Liu Fang Zhi Za Zhi (in Chinese) 2004; 11:341-69.